Latest News
July 2019
-
31 Jul 2019Researchers in the Medical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC PPU) have solved one of the mysteries of cell division, a discovery which may shed light on cancer development and one day help develop new drugs to treat the disease.
-
29 Jul 2019Food security and livelihoods for a majority of Ethiopians depends on smallholder farming, and barley is an important crop grown by over 4 million smallholder farmers for multiple uses as food, feed and as a cash crop for an emerging malting and brewing industry.
-
26 Jul 2019Potatoes have been a staple of Britain’s diet for half a millennium, but new research suggests that limited genetic differences in potato lineages has left British and American spuds vulnerable to the disease that caused the Irish potato famine. Plant scientists at the University of Dundee and the James Hutton Institute have revealed that commercial potato crops are under constant threat of late blight, the pathogen behind one of Europe’s most devastating famines, but wild potato genes might be the cure.
-
25 Jul 2019Dr Susan Wyllie, Head of the Mode of Action (MoA) group, has been promoted to tenure track Principal Investigator in the School. Her group is part of the Division of Biological Chemistry and Drug Discovery (BCDD) and the Wellcome Centre for Anti-Infectives Research (WCAIR). Background
-
24 Jul 2019The Schools of Life Sciences and Medicine are delighted to host eight of our undergraduate students who are undertaking Medical Research Scotland funded vacation scholarships with researchers in the Schools. These scholarships have the additional challenge of requiring the PI and student to apply for funding together.
-
23 Jul 2019Following on from the University wide announcement about Dundee’s overall success in the National Student Survey 2019, further details at the subject level have now been revealed. Our Biological and Biomedical Sciences programmes have again improved in position across our degrees offered through the Schools of Life Sciences and Medicine, recording an increase in overall satisfaction to a new high of 94%.
-
11 Jul 2019Researchers from the Drug Discovery Unit have been awarded the “Project of the Year 2018” from Medicines for Malaria Venture (MMV) for their discovery work on potential new drugs for malaria. The annual award goes to the scientific partners involved in that year’s most exciting project from the MMV portfolio. MMV is the world’s leading product development partnership (PDP) for discovering and developing new effective and affordable medicines to treat malaria.
-
10 Jul 2019Prof. Grahame Hardie and two of his co-workers, Diana Vara-Ciruelos and Fiona Russell, have published a review in the journal Open Biology with a title inspired by the classic novella by the Scottish author Robert Louis Stevenson. Their article discusses the controversial role in cancer of AMP-activated protein kinase (AMPK), which was first defined and named by Prof. Hardie at the University of Dundee in the late 1980s.
-
09 Jul 2019A team of scientists at the School of Life Sciences have identified a protein that makes random decisions to allow parasites to survive in their human hosts. They have been able to identify a complex that allows genes to switch on and off randomly, changing cell surface characteristics and allowing escape from the defences of the host’s immune system. This behaviour is present in genes within parasites known as trypanosomes, and also in the parasite that causes malaria, which claims hundreds of thousands of lives every year.
-
University of Dundee and Eisai enter partnership for cancer drug discovery using targeted protein...08 Jul 2019The University of Dundee has announced a new partnership with Eisai, one of the world’s leading research-based pharmaceutical companies, aiming to create innovative new drugs for the cancer field. The collaboration combines the world-leading PROTACs expertise and technology of Professor Alessio Ciulli from the Division of Biological Chemistry and Drug Discovery in the School with Eisai’s discovery research and clinical development experiences in oncology.
